Re: Editorial: benign prostatic hyperplasia

Comment

W Schäfer. J Urol. 1996 Jan.

. 1996 Jan;155(1):293.

No abstract available

Comment on

Benign prostatic hyperplasia.
Lepor H. Lepor H. J Urol. 1995 May;153(5):1540-2. doi: 10.1016/s0022-5347(01)67457-3. J Urol. 1995. PMID: 7536264 No abstract available.

[Correlation of the factors on benign prostatic hyperplasia combined with obstruction].
Chen Q, Wang YX. Chen Q, et al. Zhonghua Nan Ke Xue. 2002;8(4):299-301. Zhonghua Nan Ke Xue. 2002. PMID: 12491701 Review. Chinese.
[Clinical aspects of benign prostatic hypertrophy].
Pisani E, Montanari E, Trinchieri A. Pisani E, et al. J Urol (Paris). 1993;99(6):288-9. J Urol (Paris). 1993. PMID: 7516368 Review. French. No abstract available.
The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Gerber GS. Gerber GS. Urology. 1996 Nov;48(5):668-75. doi: 10.1016/S0090-4295(96)00249-X. Urology. 1996. PMID: 8911507 Review. No abstract available.
Benign prostatic hyperplasia (BHP) and bothersome voiding symptoms.
Hald T. Hald T. J Urol (Paris). 1995;101(1):7-9. J Urol (Paris). 1995. PMID: 7545735 Review. No abstract available.
Re: Keqin z, et al. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement (Urology 2007;70:1096-1099).
Chung SD, Chiu B, Yu HJ. Chung SD, et al. Urology. 2009 Jan;73(1):216. doi: 10.1016/j.urology.2008.07.063. Urology. 2009. PMID: 19111744 No abstract available.